ArticleIn vivo (Athens, Greece)

Prognostic Factors in Hormone-sensitive Prostate Cancer Patients Treated With Combined Androgen Blockade: A Consecutive 15-year Study at a Single Japanese Institute.

Yoshiyuki Miyazawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.